Case treated with triple therapy of lamivudine, interferon-β and prednisolone for acute exacerbation of chronic hepatitis B during pregnancy

Hepatology Research

Volumn 43, Issue 4, 2013, Pages 425-429

  Koh, Maki ^a   Shinohara, Jun ^a   Hongo, Yasushi ^a   Okazaki, Tadashi ^a   Takitani, Kimitaka ^b   Tamai, Hiroshi ^b  

^a Hirakata City Hospital   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Hepatitis B virus; Interferon ; Lamivudine; Maternal infant transmission; Pregnancy; Steroid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA INTERFERON; HEPATITIS B ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; METHYLPREDNISOLONE; PREDNISOLONE; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CHINESE; DISEASE EXACERBATION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER FUNCTION TEST; NEWBORN ASSESSMENT; PASSIVE IMMUNIZATION; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; VIRUS EXAMINATION;

EID: 84876131147     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01077.x     Document Type: Article

References (35)

1. Alter MJ. Epidemiology if hepatitis B in Europe and worldwide. J Hepatol 2003; 39: S64-9.
2. World Health Organization. Hepatitis B: World Health Organization fact sheet 204. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed August 23, 2012.
3. Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut 1996; 38: S39-42.
4. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-2.
5. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292: 771-4.
6. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. Br Med J 2006; 332: 328-36.
7. Ip HM, Lelie PN, Wong VC, Kuhns MC, Reesink HW. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989; 1: 406-10.
8. Burk RD, Hwang LY, Ho GY, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994; 170: 1418-23.
9. Wiseman E, Fraser MA, Holden S etal. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009; 190: 489-92.
10. Xu DZ, Yan YP, Choi BC etal. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67: 20-6.
11. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998; 27: 100-6.
12. Li XM, Ma L, Yang YB, Shi ZJ, Zhou SS. Clinical characteristics of fulminant hepatitis in pregnancy. World J Gastroenterol 2005; 11: 4600-3.
13. Sookoian S. Liver disease during pregnancy: acute viral hepatitis. Ann Hepatol 2006; 5: 231-6.
14. Degli Esposti S, Shah D. Hepatitis B in pregnancy: challenges and treatment. Gastroenterol Clin North Am 2011; 40: 355-72.
15. Xu WM, Cui YT, Wang L etal. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16: 94-103.
16. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10: 294-7.
17. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroentrol 2004; 10: 910-12.
18. Hung JH, Chu CJ, Sung PL etal. Lamivudine therapy in the treatment of chronic hepatitis B with acute exacerbation during pregnancy. J Chin Med Assoc 2008; 71: 155-8.
19. Connor EM, Sperling RS, Gelber R etal. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331: 1173-80.
20. Culnane M, Fowler M, Lee SS etal. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 1999; 281: 151-7.
21. Hammer SM, Saag MS, Schechter M etal. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 2006; 296: 827-43.
22. Bzowej NH. Hepatitis B therapy in pregnancy. Curr Hept Rep 2010; 9: 197-204.
23. Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry Internatioinal Interim Report for 1january 1989 through 31 January 2009. Wilmington, NC: Registry Coordinating Center, 2008; Available at: http://www.apregistry.com/forms/interim_report.pdf. Accessed August 23, 2012.
24. Peters MG. Special populations with hepatitis B virus infection. Hapatolopy 2009; 49: S146-55.
25. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007; 45: 1056-75.
26. US Food and Drug Administration. Toxicologist's review, PLA#98-0261, recombinant human interferon-β1a. Available at: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm106138.pdf. Accessed August 23, 2012.
27. Buttmann M, Rieckmann P. Interferon-beta1b in multiple sclerosis. Expert Rev Neurother 2007; 7: 227-39.
28. Boskovic R, Wide R, Wolpin J, Bauer DJ, Koren G. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 2005; 65: 807-11.
29. Amato MP, Portaccio E, Ghezzi A etal. Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology 2010; 75: 1794-802.
30. Sandberg-Wollheim M, Frank D, Goodwin TM etal. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology 2005; 65: 802-6.
31. Patti F, Cavallaro T, Lo Fermo S etal. Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis? J Neurol 2008; 255: 1250-3.
32. Ferrero S, Pretta S, Ragni N. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004; 115: 3-9.
33. Miller NM, Williamson C, Fisk NM, Glover V. Infant cortisol response after prolonged antenatal prednisolone treatment. BJOG 2004; 111: 1471-4.
34. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 1972; 81: 936-45.
35. Anderson GG, Rotchell Y, Kaiser DG. Placental transfer of methylprednisolone following maternal intravenous administration. Am J Obstet Gynecol 1981; 140: 699-701.